We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SARASOTA, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, announced today that its Board of Directors has...
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™...
Journal of Health Economics and Outcomes Research Publishes Cost Impact of the Novel, Rapid Point-of-Care Test Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic...
Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Jerome Adams, MD, MPH, will serve as a Strategic Healthcare Adviser to Lumos and...
HIGHLIGHTS Annual revenues of A$25.0 million, up 198% from FY20 Commercial Services business unit delivered $22.7 million in revenues, up 188% from FY20 Products business unit generated revenue...
Global, innovative rapid point-of-care diagnostic company plans expansion and commercialization of suite of diagnostic products following ASX IPO Rapid, point-of-care (POC) diagnostics company...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -25.641025641 | 0.039 | 0.041 | 0.029 | 3167174 | 0.03195342 | DE |
4 | -0.008 | -21.6216216216 | 0.037 | 0.049 | 0.029 | 2228902 | 0.03848001 | DE |
12 | -0.003 | -9.375 | 0.032 | 0.049 | 0.028 | 2255667 | 0.03684885 | DE |
26 | -0.012 | -29.2682926829 | 0.041 | 0.049 | 0.028 | 2547218 | 0.03696327 | DE |
52 | -0.052 | -64.1975308642 | 0.081 | 0.092 | 0.028 | 2700440 | 0.04716309 | DE |
156 | -1.011 | -97.2115384615 | 1.04 | 1.045 | 0.01 | 4308166 | 0.07889697 | DE |
260 | -1.471 | -98.0666666667 | 1.5 | 1.5 | 0.01 | 3621769 | 0.09330075 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions